Drugs / Autologous fecal microbiota transplant
Autologous fecal microbiota transplant
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03061097 | Jul 2017 → Dec 2018 | — | Microbiome Health Research Institute | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Autologous fecal microbiota transplant | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03061097 ↗ |
| Known as | aFMT | “Autologous fecal microbiota transplant (aFMT) has been proposed as a potential treatment to reduce ARBIs in nursing home residents.” PMID 35299780 ↗ Mar 2022 |
| Known as | Auto-FMP | “Autologous fecal microbiota transplant (Auto-FMP Enema)” NCT03061097 ↗ |
| Action | Restore | “The aim is to reconstitute the normal intestinal microbial flora in recipients.” NCT03061097 ↗ |
| Route | Other | “via enema” NCT03061097 ↗ |